Other functions - test the efficacy of aspirin and omeprazole for colorectal cancer chemoprevention. University of oklahoma
Ended Awarded Last action
- Contract number
- HHSN26100003
- Awardee
-
University Of Oklahoma UEI GY8NMUZQXVS7 Part of University Of Oklahoma
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $686,922
Award facts
- Contract value 100% obligated
- $686,894.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Oklahoma City, OK 73104, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Close Out | -$27 | |
| Modification | $686,922 | |
| Other Administrative Action | $0 |
About this award
This is a federal contract award for $686,894.80 by the National Cancer Institute (NCI) under the Preclinical Agent Development Assays 2012-2016 program. The award was made to the University of Oklahoma (OU) to test the efficacy of aspirin and omeprazole for colorectal cancer chemoprevention. This was a delivery order contract with a cost-no-fee pricing type, and there was no set-aside designation. OU is a public research university that provides a range of medical research, healthcare, and education services to federal agencies. As a prime contractor, OU has experience delivering radiopharmaceutical products, physician services, animal housing, and research support to agencies like the VA, DoD, HHS, and DoJ.
Quick answers
Who was awarded contract HHSN26100003?
HHSN26100003 was awarded to University Of Oklahoma by National Cancer Institute (National Institutes of Health) on September 20, 2012.
How much is contract HHSN26100003 worth?
The government has obligated $686,922 on HHSN26100003. Its current value, with exercised options, is $686,895.
Is contract HHSN26100003 an order under another contract?
Yes. HHSN26100003 is a delivery order under HHSN261201200020I, an indefinite delivery contract, on Preclinical Agent Development Assays 2012-2016.
Was contract HHSN26100003 competed?
The extent of competition for HHSN26100003 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award